相关实验视频

Updated: Jul 11, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.9K

在粉样性疾病的背景下探索类纳米复合物

Nicholas Andrikopoulos1,2, Huayuan Tang3,4, Yue Wang1,5

  • 1Nanomedicine Center, The Great Bay Area National Institute for Nanotechnology Innovation, 136 Kaiyuan Avenue, Guangzhou, 510700, China.

Angewandte Chemie (International ed. in English)
|November 9, 2023
PubMed
概括

治疗性和纳米颗粒形成强大的纳米复合物,用于对抗粉样类疾病. 需要进一步的研究来了解它们的化学成分,并优化它们对这些衰弱条件的应用.

关键词:
粉样蛋白疾病 粉样蛋白疾病氨基粉症是什么 氨基粉症纳米颗粒是如何形成的这是一种类.它具有皮多米米特作用.

更多相关视频

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.4K
Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.2K

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.6K